Despite many advances in targeted therapeutics and diagnostics, there is still a need for specific, effective therapies without side effects and mechanisms for early detection that ensure therapies have the best opportunity to be timely and effective.
Having witnessed substantial technological advances in the field of nanotechnology, scientists at the Imaging Research Center have been inspired to tackle these clinical problems with a nanomedicine approach. This involves research and technology development at the atomic, molecular, or macromolecular levels for the creation and use of functionalized structures, devices, and systems that exist at the nanoscale, which is about 1-100 nanometers. The nanoscale cannot be seen with the naked eye and requires the use of powerful microscopes.
Our goal is to develop and explore nanotechnology for the management of cardiovascular disease and cancer. We can inject the body with contrast chemicals to target disease.